These include bisphosphonates, tetracycline and fluoroquinolone antibiotics, and levothyroxine
Importantly, only Semaglutide and Tirzepatide are FDA-approved and available todayRetatrutide remains investigational, with realistic approval falling between the second half of 2027 and mid-2028
Important safety considerations include a boxed warning for thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), and pregnancy avoidance (with a 2-month washout period before conception)
Of those who completed oral semaglutide 50 mg treatment, 80% were on the 50 mg dose at week 68
This leads to an increase in whole body radical burden, and increased oxidative damage to cell membranes
Three sessions with a nutrition expert and health coach to keep you on track